200 related articles for article (PubMed ID: 2808202)
1. Activity of meropenem, against gram-positive bacteria.
Kayser FH; Morenzoni G; Strässle A; Hadorn K
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():101-12. PubMed ID: 2808202
[TBL] [Abstract][Full Text] [Related]
2. Review of the in vitro spectrum of activity of imipenem.
Jones RN
Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci.
Kitzis MD; Acar JF; Gutmann L
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():125-32. PubMed ID: 2808204
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus.
Sumita Y; Nouda H; Kanazawa K; Fukasawa M
Antimicrob Agents Chemother; 1995 Apr; 39(4):910-6. PubMed ID: 7785994
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of oral cephalosporin BAY v 3522 compared with other oral cephalosporins.
Locher R; Strässle A; Kayser FH
Drugs Exp Clin Res; 1990; 16(10):515-25. PubMed ID: 2100734
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
Ueda Y; Sunagawa M
Antimicrob Agents Chemother; 2003 Aug; 47(8):2471-80. PubMed ID: 12878507
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci.
Kurazono M; Ida T; Yamada K; Hirai Y; Maruyama T; Shitara E; Yonezawa M
Antimicrob Agents Chemother; 2004 Aug; 48(8):2831-7. PubMed ID: 15273088
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
Nagano R; Shibata K; Adachi Y; Imamura H; Hashizume T; Morishima H
Antimicrob Agents Chemother; 2000 Mar; 44(3):489-95. PubMed ID: 10681308
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
Ubukata K; Hikida M; Yoshida M; Nishiki K; Furukawa Y; Tashiro K; Konno M; Mitsuhashi S
Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313
[TBL] [Abstract][Full Text] [Related]
10. Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3.
Sumita Y; Fukasawa M
J Antimicrob Chemother; 1995 Jul; 36(1):53-64. PubMed ID: 8537284
[TBL] [Abstract][Full Text] [Related]
11. Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteins.
Piddock LJ; Traynor EA; Wise R
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():59-64. PubMed ID: 2732144
[TBL] [Abstract][Full Text] [Related]
12. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
Yang Y; Bhachech N; Bush K
J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785
[TBL] [Abstract][Full Text] [Related]
13. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.
Chanal C; Sirot D; Chanal M; Cluzel M; Sirot J; Cluzel R
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():133-41. PubMed ID: 2808205
[TBL] [Abstract][Full Text] [Related]
14. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
[TBL] [Abstract][Full Text] [Related]
15. Production of low-affinity penicillin-binding protein by low- and high-resistance groups of methicillin-resistant Staphylococcus aureus.
Murakami K; Nomura K; Doi M; Yoshida T
Antimicrob Agents Chemother; 1987 Sep; 31(9):1307-11. PubMed ID: 3499861
[TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.
Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K
Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.
Chambers HF
Antimicrob Agents Chemother; 1995 Feb; 39(2):462-6. PubMed ID: 7726516
[TBL] [Abstract][Full Text] [Related]
18. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H
Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
Fukuoka T; Ohya S; Utsui Y; Domon H; Takenouchi T; Koga T; Masuda N; Kawada H; Kakuta M; Kubota M; Ishii C; Ishii C; Sakagawa E; Harasaki T; Hirasawa A; Abe T; Yasuda H; Iwata M; Kuwahara S
Antimicrob Agents Chemother; 1997 Dec; 41(12):2652-63. PubMed ID: 9420035
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of carbapenem compounds to anti-Haemophilus influenzae activity and affinity for penicillin-binding proteins. Effect of 1 beta-methyl group and C-2 side chain.
Kanazawa K; Nouda H; Sunagawa M
J Antibiot (Tokyo); 1997 Feb; 50(2):162-8. PubMed ID: 9099227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
